ePadlink VP9840 ePad-ink Signature Pad LCD USB - Forbedre digital signatur arbeidsflyt
ePadlink VP9840 ePad-ink Signature Pad LCD USB - Forbedre digital signatur arbeidsflyt
ePadlink VP9840
- Free Shipping
- 1 Year Warranty
- 30 Day Returns
- Carbon Neutral
hrs
mins
Fraktinformasjon
ePadlink
VP9840
ePad-ink, Interlinks mest utbredte enhet for innhenting av elektroniske signaturer, brukes over hele verden for å fange elektroniske signaturer, enten signeringen skjer i filialen eller i feltet. Med en LCD-skjerm som lyser opp når en e-signatur påføres eller bekreftelsestekst vises, gir den interaktive visuelle tilbakemeldingen en forbedret brukeropplevelse. Ergonomisk, bærbar, og pakket sammen med IntegriSign Desktop for e-signering av Microsoft Word, Excel, Outlook og Adobe Acrobat-dokumenter, er ePad-ink en best-i-klassen e-signaturløsning. Kraftige SDK-er kan brukes til å implementere en e-signaturløsning i ethvert miljø.
Return Policy |
Time to Return |
Standard Return Policy |
We offer a hassle-free 30-day returns policy for domestic (US) orders, excluding non-refundable items. Refund or Replacement within 30 days of the delivery date. All products that fall under the Standard Return Policy qualify for our 30-Day Hassle-Free Returns. Please see the section above for more details. |
Replacement Only Return Policy |
Replacement within 30 days of the delivery date. |
Manufacturer Only Return Policy |
Covered by the manufacturer's warranty. Please refer to the terms and conditions for the manufacturer's warranty or contact the manufacturer. |
Holiday Extended Return Policies |
Extended Holiday Return Policy.Qualifying purchases of products displaying the " Extended Holiday Return Policy ", from November 1st, 2023 to December 25, 2023, are eligible for a Refund or Replacement until January 31, 2024. Extended Holiday Replacement-Only Return PolicyQualifying purchases of products displaying the " Extended Holiday Replacement-Only Return Policy ", from November 1st, 2023 to December 25, 2023, are eligible for a Replacement until January 31, 2024. |